相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors
Joel Castro et al.
GUT (2017)
Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update
Kathleen T. Brady et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment
Alessandra Pacini et al.
EXPERIMENTAL NEUROLOGY (2016)
Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief
Edward C. Emery et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates
Deborah Dowell et al.
HEALTH AFFAIRS (2016)
Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis
Wei Jiang et al.
JOURNAL OF IMMUNOLOGY (2016)
Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival
Stephanie St-Pierre et al.
PLOS ONE (2016)
Forecasting the opioid epidemic
Donald S. Burke
SCIENCE (2016)
Phosphocholine - an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors
K. Richter et al.
SCIENTIFIC REPORTS (2016)
αS-conotoxin GVIIIB potently and selectively blocks (α9α10 nicotinic acetylcholine receptors
Sean B. Christensen et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics
Tuan Trang et al.
JOURNAL OF NEUROSCIENCE (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist
Sulan Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors
Shaoqiong Xu et al.
SCIENTIFIC REPORTS (2015)
Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Sarasa A. Mohammadi et al.
TOXINS (2015)
Molecular Interaction of α-Conotoxin RgIA with the Rat α9α10 Nicotinic Acetylcholine Receptor
Layla Azam et al.
MOLECULAR PHARMACOLOGY (2015)
Novel Mechanism of Voltage-Gated N-type (Cav2.2) Calcium Channel Inhibition Revealed through α-Conotoxin Vc1.1 Activation of the GABAB Receptor
Thuan G. Huynh et al.
MOLECULAR PHARMACOLOGY (2015)
Glial role in oxaliplatin-induced neuropathic pain
Lorenzo Di Cesare Mannelli et al.
EXPERIMENTAL NEUROLOGY (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and. α-conotoxin Vc1.1 via GABAB receptor activation
Geza Berecki et al.
JOURNAL OF GENERAL PHYSIOLOGY (2014)
History of the G Protein-Coupled Receptor (GPCR) Assays From Traditional to a State-of-the-Art Biosensor Assay
Kanako Miyano et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia
Sarasa Mohammadi et al.
MOLECULAR PAIN (2014)
α-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement
Lorenzo Di Cesare Mannelli et al.
PAIN (2014)
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
Mohamed E. Abazeed et al.
CANCER RESEARCH (2013)
Intrathecal Ziconotide: A Review of Its Use in Patients with Chronic Pain Refractory to Other Systemic or Intrathecal Analgesics
Mark Sanford
CNS DRUGS (2013)
Differential modulation of EAE by α9☆- and β2☆-nicotinic acetylcholine receptors
Alain R. Simard et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Identification of CaV channel types expressed in muscle afferent neurons
Renuka Ramachandra et al.
JOURNAL OF NEUROPHYSIOLOGY (2013)
A Novel Inhibitor of α9α10 Nicotinic Acetylcholine Receptors from Conus vexillum Delineates a New Conotoxin Superfamily
Sulan Luo et al.
PLOS ONE (2013)
Novel Small Molecule α9α10 Nicotinic Receptor Antagonist Prevents and Reverses Chemotherapy-Evoked Neuropathic Pain in Rats
Elzbieta P. Wala et al.
ANESTHESIA AND ANALGESIA (2012)
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
Xiao-Min Wang et al.
CYTOKINE (2012)
Oxaliplatin: a review of approved uses
Alexander Stein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins
Hartmut Cuny et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA
Layla Azam et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
α-Conotoxin PeIA[S9H,V10A,E14N] Potently and Selectively Blocks α6β2β3 versus α6β4 Nicotinic Acetylcholine Receptors
Arik J. Hone et al.
MOLECULAR PHARMACOLOGY (2012)
Identification of Human Ether-a-go-go Related Gene Modulators by Three Screening Platforms in an Academic Drug-Discovery Setting
Xi-Ping Huang et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2010)
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Carol Kilkenny et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2010)
Alpha9 nicotinic acetylcholine receptors and the treatment of pain
J. Michael McIntosh et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Analgesic α-Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation
Brid Callaghan et al.
JOURNAL OF NEUROSCIENCE (2008)
Molecular determinants of species-specific activation or blockade of TRPA1 channels
Jun Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Species-specific pharmacology of trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists
Lana Klionsky et al.
MOLECULAR PAIN (2007)
Diabetic neuropathy - a review
Gerard Said
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor
Bruce G. Livett et al.
TOXICON (2006)
Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors
Michelle Vincler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
α-RgIA:: A novel conotoxin that specifically and potently blocks the α9α10 nAChR
M Ellison et al.
BIOCHEMISTRY (2006)
Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones
N Satkunanathan et al.
BRAIN RESEARCH (2005)
A novel α-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat α9α10 and α7 nicotinic cholinergic receptors
JM McIntosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Characterization of the human nicotinic acetylcholine receptor subunit alpha (α) 9 (CHRNA9) and alpha (α) 10 (CHRNAIO) in lymphocytes
HS Peng et al.
LIFE SCIENCES (2004)
Lodo-α-conotoxin MI selectively binds the α/δ subunit interface of muscle nicotinic acetylcholine receptors
SQ Luo et al.
BIOCHEMISTRY (2004)
A novel α-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo
DW Sandall et al.
BIOCHEMISTRY (2003)
Pharmacological characterisation of a cell line expressing GABAB1b and GABAB2 receptor subunits
WD Hirst et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat
G Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2001)
分享论文
